Proteomics International: Funding, Investors & Team (Sep 2026)
Proteomics International is a cutting-edge medical technology company that leads in the fields of predictive diagnostics and bio-analytical services. Their focus lies in proteomics, which involves studying the structure and function of proteins on a large scale. The company's main objective is to utilize their expertise in proteins to create and market diagnostic tests for chronic illnesses that currently lack effective medical solutions.
Proteomics International has raised $4.6M across 2 funding rounds on record, the most recent an undisclosed round of $320k announced in Nov 2025.
That round is below the $8.0M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Proteomics International Company Profile and Key Stats
Latest funding round on record: Nov 2025.
Proteomics International Funding Rounds
Proteomics International raised $4.3M in an undisclosed round announced in Jan 2024.
1.8 years later, an undisclosed round of $320k was announced in Nov 2025.
Proteomics International Founders and Leadership Team
Contact details for the Proteomics International team: 1 of 1 has an email address on file.
Start 14-day free trial →Proteomics International Funding Compared to Other Biotechnology Startups
Proteomics International's latest round of $320k is below the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Proteomics International in Biotechnology and Perth
Companies Similar to Proteomics International
AdvanCell is a company that focuses on developing innovative cancer treatments using alpha-emitting isotopes…
The objective of Fluent is to seamlessly integrate humans with AI, improving interaction and communication…
Mesoblast is a developer of biologic products for the broad field of regenerative medicine. Mesoblast's…
Microba Life Sciences Ltd. provides consumers, doctors, and researchers with gut microbiome testing services…
Algenie was founded on a simple realization: algae has the potential to save the earth, but only if it is…
Paradigm Pharmaceuticals is a global biopharmaceutical company driven to discover, develop, and deliver…
Imugene is a publicly-listed biotechnology company with operations in America and Europe,
BiomeBank’s mission is to treat and prevent disease by restoring gut microbial ecology
Telix Pharmaceuticals Ltd is a clinical-stage biotechnology company engaged in developing and commercializing…
Cauldron Ferm is a technique that speeds up the production of precision fermented prototypes to commercial…
HydGene Renewables is developing a biotechnology platform that produces on-site green hydrogen from waste…
Swan Genomics is focused on commercialising an innovative new approach to DNA sequencing to deliver more…
Proteomics International Funding FAQs
What does Proteomics International do?
Proteomics International is a cutting-edge medical technology company that leads in the fields of predictive diagnostics and bio-analytical services. Their focus lies in proteomics, which involves studying the structure and function of proteins on a large scale. The company's main objective is to utilize their expertise in proteins to create and market diagnostic tests for chronic illnesses that currently lack effective medical solutions.
How much funding has Proteomics International raised?
Proteomics International has raised $4.6M across 2 rounds on record. The most recent is an undisclosed round of $320k announced in Nov 2025.
When did Proteomics International last raise funding?
Proteomics International's most recent funding round on record is an undisclosed round of $320k, announced in Nov 2025.
Who founded Proteomics International?
FundedIQ lists Richard Lipscombe (Founder) at Proteomics International.
Where is Proteomics International headquartered?
Proteomics International is based in Perth, Western Australia, Australia.
How many employees does Proteomics International have?
Proteomics International is in the 11-50 employee band.
How does Proteomics International's funding compare to other Biotechnology startups?
Proteomics International's latest round of $320k is below the $8.0M median round size for Biotechnology companies on FundedIQ across 4,179 tracked companies over the last two years.
About FundedIQ's Proteomics International Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Proteomics International is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.